Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$5.48 USD
-0.10 (-1.79%)
Updated May 17, 2024 04:00 PM ET
After-Market: $5.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/25/2024
Time: -- |
6/2024 | $0.02 | 0.00% |
Earnings Summary
For their last quarter, Vanda Pharmaceuticals (VNDA) reported earnings of -$0.07 per share, missing the Zacks Consensus Estimate of $0.05 per share. This reflects a negative earnings surprise of 240.00%. Look out for VNDA's next earnings release expected on July 25, 2024. For the next earning release, we expect the company to report earnings of $0.02 per share, reflecting a year-over-year decrease of 33.33%.
Earnings History
Price & Consensus
Zacks News for VNDA
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
VNDA: What are Zacks experts saying now?
Zacks Private Portfolio Services